Md Rezaul Islam

Dr. Md Rezaul Islam


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2018 in Nature
Verified
Journal Article
Closed access
PDF file
AWAnn-Christin Wendeln
Ann-Christin Wendeln
KDKaroline Degenhardt
Karoline Degenhardt
Lalit KauraniLalit Kaurani
Lalit Kaurani
MGMichael Gertig
Michael Gertig
TUThomas Ulas
Thomas Ulas
JNJonas J. Neher
Jonas J. Neher

1 April 2018 in Cell Reports
Verified
Journal Article
Open access
EBEva Benito
Eva Benito
CKCemil Kerimoglu
Cemil Kerimoglu
BRBinu Ramachandran
Binu Ramachandran
TPTonatiuh Pena-Centeno
Tonatiuh Pena-Centeno
GJGaurav Jain
Gaurav Jain
André FischerAndré Fischer
André Fischer
Physical exercise in combination with cognitive training is known to enhance synaptic plasticity, learning, and memory and lower the risk for various complex diseases including Alzheimer's disease. Here, we show that exposure of adult male mice to an environmental enrichment paradigm leads to enhancement of synaptic plasticity and cognition also in the next generation. We show that this effect is mediated through sperm RNA and especially miRs 212/132. In conclusion, our study reports intergenerational inheritance of an acquired cognitive benefit and points to specific miRs as candidates mechanistically involved in this type of transmission.

1 December 2013 in Journal of Young Pharmacists
Verified
Journal Article
Open access
MIMd Rezaul Islam
Md Rezaul Islam
AZAubhishek Zaman
Aubhishek Zaman
IJIffat Jahan
Iffat Jahan
RCRajib Chakravorty
Rajib Chakravorty
SCSajib Chakraborty
Sajib Chakraborty
Acetylcholine-esterase (AchE) inhibitors are one of the most potent drug molecules against Alzheimer's disease (AD). But, patients treated with current AchE inhibitors often experience severe side effects. Quercetin is a plant flavonoid compound which can act as AchE inhibitor and it may be a better alternative to current AchE inhibitors in terms of effectiveness with no or fewer side effects. The aim of the study was to compare quercetin with conventional AchE inhibitors to search for a better drug candidate. Physico-chemical properties of conventional drugs and quercetin were predicted using bioinformatics tools. Molecular docking of these compounds on the active site of AchE was performed using AutoDock and comparative analysis was performed. Later, modification on the basic structure of quercetin with different functional groups was done to perform QSAR analysis. Quercetin showed a similar drug likeness score to the conventional drugs. The binding strength for quercetin in the active site of the enzyme was -8.8 kcal/mol, which was considerably higher than binding scores for some of the drugs such as donepezil (binding score -7.9 kcal/mol). Fifteen hydrogen bonds were predicted between quercetin and the enzyme whereas conventional drugs had fewer or even no hydrogen bonds. It implies that quercetin can act as a better inhibitor than conventional drugs. To find out even better inhibitor, similar structures of quercetin were searched through SIMCOMP database and a methylation in the 4-OH position of the molecule showed better binding affinity than parent quercetin. Quantitative structure activity relationship study indicated that O-4 methylation was specifically responsible for better affinity. This in silico study has conclusively predicted the superiority of the natural compound quercetin over the conventional drugs as AchE inhibitor and it sets the need for further in-vitro study of this compound in future.

1 November 2018 in Neurobiology of Disease
Verified
Journal Article
Closed access
IPIsabel Paiva
Isabel Paiva
GJGaurav Jain
Gaurav Jain
DLDiana F. Lázaro
Diana F. Lázaro
KJKristina Gotovac Jerčić
Kristina Gotovac Jerčić
THThomas Hentrich
Thomas Hentrich
Tiago OuteiroTiago Outeiro
Tiago Outeiro

24 July 2014 in Advances in Bioinformatics
Verified
Journal Article
Open access
PDF file
MSM. Sadman Sakib
M. Sadman Sakib
MIMd Rezaul Islam
Md Rezaul Islam
AHA. K. M. Mahbub Hasan
A. K. M. Mahbub Hasan
ANA. H. M. Nurun Nabi
A. H. M. Nurun Nabi
This study aims to design epitope-based peptides for the utility of vaccine development by targeting glycoprotein G and envelope protein F of Nipah virus (NiV) that, respectively, facilitate attachment and fusion of NiV with host cells. Using various databases and tools, immune parameters of conserved sequence(s) from G and F proteins of different isolates of NiV were tested to predict probable epitope(s). Binding analyses of the peptides with MHC class-I and class-II molecules, epitope conservancy, population coverage, and linear B cell epitope prediction were analyzed. Predicted peptides interacted with seven or more MHC alleles and illustrated population coverage of more than 99% and 95%, for G and F proteins, respectively. The predicted class-I nonamers, SLIDTSSTI and EWISIVPNF, superimposed on the putative decameric B cell epitopes, were also identified as core sequences of the most probable class-II 15-mer peptides GPKVSLIDTSSTITI and EWISIVPNFILVRNT. These peptides were further validated for their binding to specific HLA alleles usingin silicodocking technique. Ourin silicoanalysis suggested that the predicted epitopes, either GPKVSLIDTSSTITI or EWISIVPNFILVRNT, could be a better choice as universal vaccine component against NiV irrespective of different isolates which may elicit both humoral and cell-mediated immunity.

21 September 2018 in Toxin Reviews
Verified
Journal Article
Closed access
MMMustafa Mahfuz
Mustafa Mahfuz
MGMd Amran Gazi
Md Amran Gazi
MHMuttaquina Hossain
Muttaquina Hossain
MIMd Rezaul Islam
Md Rezaul Islam
SFShah Mohammad Fahim
Shah Mohammad Fahim
TATahmeed Ahmed
Tahmeed Ahmed